BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PTCMA - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ptcma.org.za
X-WR-CALDESC:Events for PTCMA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Africa/Johannesburg
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0200
TZNAME:SAST
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Africa/Johannesburg:20260821T083000
DTEND;TZID=Africa/Johannesburg:20260821T100000
DTSTAMP:20260804T094308Z
CREATED:20260112T112904Z
LAST-MODIFIED:20260804T094308Z
UID:13411-1787301000-1787306400@ptcma.org.za
SUMMARY:Virtual CPD - 21 August 2026
DESCRIPTION:Programme\n08h45: Login and sound check \n09h00: Changing the Landscape of EGFR-Mutated NSCLC: Targeted Therapy\, FLAURA Evidence\, and CNS Protection \nPresented by: Dr. Waldemar SZPAK (Oncologist) \n  \n\n\n\n\nClick to register\n\n\n\n\n\n\nThank you to AstraZeneca for providing the unconditional educational sponsorship\, making this session possible.
URL:https://ptcma.org.za/event/virtual-cpd-21-august-2026/
CATEGORIES:Morning,VCPD
ATTACH;FMTTYPE=image/jpeg:https://ptcma.org.za/wp-content/uploads/2026/01/Lung-cancer-cells-600x400-1.jpg
END:VEVENT
END:VCALENDAR